Podcasts about eye on ocular health

CME credits: 0.25 Valid until: 07-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-adherence-and-persistence-with-durable-anti-vegf-therapies-for-namd/18068/ This case consult with Dr Do and Dr Kaiser will consider a treatment-experienced patient referred for a 2nd opinion with decreased vision and prior diagnosis of neovascular AMD (nAMD). Dr Do and Dr Kaiser will discuss the recently approved anti-vascular endothelial growth factor (VEGF) agents with greater durability and longer dosing intervals that can decrease treatment burden. These retina specialists will evaluate the treatment responses in this patient and discuss whether to modify dosing intervals or switch therapies. This case illustrates the burden of care for patients with neovascular AMD (nAMD), and shows how to use the more durable anti-VEGF therapies in clinical practice to reduce treatment burden.=

CME credits: 0.25 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2vegf-a-inhibition-anatomical-benefits/18009/ What evidence do we have that blocking Ang-2 and VEGF-A is beneficial for patients? Tune in to hear Dr. Jennifer Lim and Dr. Carl Regillo examine the anatomical and biomarker evidence surrounding dual inhibition of Ang-2 and VEGF-A. Find out how bispecific targeting can benefit patients with neovascular age-related macular degeneration and diabetic macular edema. =

CME credits: 0.25 Valid until: 15-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2-vegf-a-inhibition-durability-and-drying/18008/ What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the biomarkers of Ang-2 and VEGF-A suppression. Hear how to achieve earlier and faster fluid resolution in both neovascular age-related macular degeneration and diabetic macular edema.=

CME credits: 0.50 Valid until: 25-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/extending-treatment-durability-with-next-generation-neovascular-amd-therapies/18067/ The CME News Broadcast webinar will engage retina specialists and treating ophthalmologists with education needed to integrate the new durable anti-vascular endothelial growth factor (VEGF) therapies for neovascular AMD (nAMD) into clinical practice. This will include recent data on the efficacy, safety, and durability of these new therapies and the imaging approaches that can be used to facilitate monitoring of nAMD disease progression and treatment success. This activity will create understanding of the new durable therapies and how they can extend dosing intervals. The expert faculty will discuss the latest data on new anti-VEGF therapies with the potential to reduce treatment burden and improve vision outcomes. =

CME credits: 0.25 Valid until: 17-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/improving-meibomian-gland-dysfunction-with-device-management/14810/ How can more advanced measures improve meibomian gland function to relieve dry eye symptoms and improve refraction? Listen as Dr. Cynthia Matossian and Dr. Jillian Ziemanski discuss additional approaches you can try with your patients.=

CME credits: 1.00 Valid until: 20-12-2023 Claim your CME credit at https://reachmd.com/programs/cme/updates-in-retinal-disease-care-keeping-an-eye-on-emerging-anti-vegf-therapies-improved-outcomes/15892/ This program will deliver much-needed, up-to-date information on evidence-based strategies for dosing available anti-VEGF therapies and for integrating newly approved therapies into practice; with reviews of current clinical data from emerging retinal disease therapies.=

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Yannis Paulus, MD, FACS Early diagnosis of retinal diseases can make quite a difference when it comes to preserving our patients' vision. But what are the symptoms we should be looking out for, and how can we optimize screening opportunities with our patients? Find out with Dr. Charles Turck as he explores effective strategies for detecting and treating retinal diseases early with Dr. Yannis Paulus from the University of Michigan Kellogg Eye Center.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Diana Do, MD Guest: Nathan Steinle, MD From comorbidities to adverse events, there's a lot to consider when treating retinal diseases. But are you prioritizing your patient's preferences? Dr. Diana Do and Dr. Nathan Steinle join Dr. Charles Turck to share strategies to better incorporate your patients' needs into their treatment plan.

Host: Jennifer Caudle, DO Guest: Christina Y. Weng, MD, MBA What treatment options are currently available for retinal diseases—and do we need to reevaluate our standard of care? Dr. Jennifer Caudle is joined by Dr. Christina Weng to take a look at current approaches to management for diabetic retinopathy, diabetic macular edema, wet age-related macular degeneration, and macular edema following retinal vein occlusion.

Guest: Charles Wykoff, MD, PhD Learn more about wet or dry retinal diseases and some of their most common challenges from Dr. Charles Wykoff, a board-certified medical and surgical retina specialist and ophthalmologist at Retina Consultants of Texas in Houston.

Guest: Regina Benjamin, MD, MS As healthcare providers, it’s our duty to emphasize the importance of preventing the eye-health consequences associated with diabetes, particularly as it pertains to health disparities and underserved populations. This activity featuring Dr. Regina Benjamin serves as a call to action by discussing the essential roles that all healthcare professionals play in the overall eye-health of our patients to reduce visual impairment due to diabetic retinopathy. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Host: Jennifer Caudle, DO Guest: Anne Negrin, MD Since eye issues are becoming increasingly common in patients with rheumatological conditions, it's now more vital than ever that physicians are aware of their common symptoms. Joining Dr. Jennifer Caudle is Dr. Anne Negrin, an ophthalmologist in New York, to break down these symptoms and to focus on rheumatological concerns that ophthalmologists see in practice.

Host: Jennifer Caudle, DO Guest: Anne Negrin, MD Since eye issues are becoming increasingly common in patients with rheumatological conditions, it’s now more vital than ever that physicians are aware of their common symptoms. Joining Dr. Jennifer Caudle is Dr. Anne Negrin, an ophthalmologist in New York, to break down these symptoms and to focus on rheumatological concerns that ophthalmologists see in practice.

Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children's Hospital of Philadelphia.

Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina.A group of researchers from across the US tested an alternative treatment using an injectable medication called ranibizumab, to see if it would be as effective as the laser therapy. They studied more than 300 patients with PDR, assigning them to either receive standard laser therapy or an injection into the eye. In total, they treated close to 400 eyes.Outcomes, especially loss of vision, were compared at two years. Over the two year period, researchers found that patients receiving the injections of medication had fewer side effects and did somewhat better in terms of vision loss than those who received laser therapy. [Watch more videos of The JAMA Report]

[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina.A group of researchers from across the US tested an alternative treatment using an injectable medication called ranibizumab, to see if it would be as effective as the laser therapy. They studied more than 300 patients with PDR, assigning them to either receive standard laser therapy or an injection into the eye. In total, they treated close to 400 eyes.Outcomes, especially loss of vision, were compared at two years. Over the two year period, researchers found that patients receiving the injections of medication had fewer side effects and did somewhat better in terms of vision loss than those who received laser therapy. [Watch more videos of The JAMA Report]

[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina.A group of researchers from across the US tested an alternative treatment using an injectable medication called ranibizumab, to see if it would be as effective as the laser therapy. They studied more than 300 patients with PDR, assigning them to either receive standard laser therapy or an injection into the eye. In total, they treated close to 400 eyes.Outcomes, especially loss of vision, were compared at two years. Over the two year period, researchers found that patients receiving the injections of medication had fewer side effects and did somewhat better in terms of vision loss than those who received laser therapy. [Watch more videos of The JAMA Report]

Host: Jennifer Caudle, DO Dr. Jennifer Caudle welcomes Dr. Patrick Spencer, Chairman of the Department of Ophthalmology at Grandview Medical Center in Dayton, Ohio. Their discussion centers on primary care manifestations of sickle cell retinopathy, from early to late-stage presentations and the gold standard treatment approaches along this disease course.

Host: Jennifer Caudle, DO Dr. Jennifer Caudle welcomes Dr. Patrick Spencer, Chairman of the Department of Ophthalmology at Grandview Medical Center in Dayton, Ohio. Their discussion centers on primary care manifestations of sickle cell retinopathy, from early to late-stage presentations and the gold standard treatment approaches along this disease course.

Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Dr. Gail L. Torkildsen, staff ophthalmologist at Andover Eye Associates and one of the leading Dry Eye Principal Investigators in the world. Dr. Torkildsen has served as P.I. on over 20 client-sponsored Dry Eye studies since 2002. In this discussion she takes listeners on a tour of common eye problems faced in primary care, and how clinicians can better prepare themselves to address issues such as Meibobian gland disorders, blepharitis, dry eyes, and conjunctivitis with greater confidence.

Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Dr. Gail L. Torkildsen, staff ophthalmologist at Andover Eye Associates and one of the leading Dry Eye Principal Investigators in the world. Dr. Torkildsen has served as P.I. on over 20 client-sponsored Dry Eye studies since 2002. In this discussion she takes listeners on a tour of common eye problems faced in primary care, and how clinicians can better prepare themselves to address issues such as Meibobian gland disorders, blepharitis, dry eyes, and conjunctivitis with greater confidence.

Host: Brian P. McDonough, MD, FAAFP A clinical pearl in the arena of eye care is that serious eye problems tend to manifest serious symptoms and signs, which makes vision loss one of the key findings in a diagnostic workup. Yet vision testing is commonly neglected in primary care practice even when patients present with eye-related complaints. What are the most important steps a clinician can take when assessing eye problems, and where does the primary care practitioner fit into the ophthalmologic care continuum? Dr. Brian McDonough welcomes Dr. Sumitra Khandelwal, Assistant Professor of Ophthalmology at Baylor College of Medicine, to examine the top issues in eye care for generalists and ophthalmic specialists.

Host: Brian P. McDonough, MD, FAAFP A clinical pearl in the arena of eye care is that serious eye problems tend to manifest serious symptoms and signs, which makes vision loss one of the key findings in a diagnostic workup. Yet vision testing is commonly neglected in primary care practice even when patients present with eye-related complaints. What are the most important steps a clinician can take when assessing eye problems, and where does the primary care practitioner fit into the ophthalmologic care continuum? Dr. Brian McDonough welcomes Dr. Sumitra Khandelwal, Assistant Professor of Ophthalmology at Baylor College of Medicine, to examine the top issues in eye care for generalists and ophthalmic specialists.

Host: Brian P. McDonough, MD, FAAFP On average, more than 90% of adults spend more than two hours each day using a digital device, and for 60% of the population, that daily use pattern extends beyond five hours. Regardless of the reasons why, all that time can take a toll on the eyes and lead to digital eye strain. Speaking on the health implications of digital eye strain is Dr. Dora Adamopolous, optometrist in practice in Alexandia, VA.

Host: Brian P. McDonough, MD, FAAFP On average, more than 90% of adults spend more than two hours each day using a digital device, and for 60% of the population, that daily use pattern extends beyond five hours. Regardless of the reasons why, all that time can take a toll on the eyes and lead to digital eye strain. Speaking on the health implications of digital eye strain is Dr. Dora Adamopolous, optometrist in practice in Alexandia, VA.

Guest: Stephen Orlin, MD This Excerpt from the Podium comes from Prova Education's "From Guidelines to Practice" program in New York City and features Dr. Stephen Orlin, Associate Professor of Ophthalmology at the University of Pennsylvania School of Medicine. Dr. Orlin speaks on the various types of conjunctivitis, their common etiologies, and their respective management approaches.

Guest: Stephen Orlin, MD This Excerpt from the Podium comes from Prova Education's "From Guidelines to Practice" program in New York City and features Dr. Stephen Orlin, Associate Professor of Ophthalmology at the University of Pennsylvania School of Medicine. Dr. Orlin speaks on the various types of conjunctivitis, their common etiologies, and their respective management approaches.

Guest: Stephen Orlin, MD This Excerpt from the Podium features Dr. Stephen Orlin, Associate Professor of Ophthalmology at the University of Pennsylvania School of Medicine, speaking on the patient workup for red eye at Prova Education's "From Guidelines to Practice" program in New York City.

Guest: Stephen Orlin, MD This Excerpt from the Podium features Dr. Stephen Orlin, Associate Professor of Ophthalmology at the University of Pennsylvania School of Medicine, speaking on the patient workup for red eye at Prova Education's "From Guidelines to Practice" program in New York City.

Guest: Stephen Orlin, MD The classic "red eye" presentation by your patient may be a common sighting in your clinical practice, but are you truly up to date on the various causes, treatments, and pitfalls that clinicians encounter when confronting ocular problems? Discussing this issue is Dr. Stephen Orlin, Associate Professor of Ophthalmology, Director of the Cornea Department, and Co-Director of the Refractive Surgery Service at the University of Pennsylvania.

Guest: Stephen Orlin, MD The classic "red eye" presentation by your patient may be a common sighting in your clinical practice, but are you truly up to date on the various causes, treatments, and pitfalls that clinicians encounter when confronting ocular problems? Discussing this issue is Dr. Stephen Orlin, Associate Professor of Ophthalmology, Director of the Cornea Department, and Co-Director of the Refractive Surgery Service at the University of Pennsylvania.

Host: Lee Freedman, MD Guest: Jean Bennett, MD, PhD Host Dr. Lee Freedman and Dr. Jean Bennett, the FM Kirby Professor of Epistemology at the University of Pennsylvania School of Medicine, explore how the study of molecular genetics of inherited retinal degenerations can help develop treatments for congenital eye disorders, as well as adult-onset diseases and possibly disorders that affect the body outside the eye.

Host: Lee Freedman, MD Guest: Jean Bennett, MD, PhD Host Dr. Lee Freedman and Dr. Jean Bennett, the FM Kirby Professor of Epistemology at the University of Pennsylvania School of Medicine, explore how the study of molecular genetics of inherited retinal degenerations can help develop treatments for congenital eye disorders, as well as adult-onset diseases and possibly disorders that affect the body outside the eye.

Host: Lee Freedman, MD Guest: Jean Bennett, MD, PhD Host Dr. Lee Freedman and Dr. Jean Bennett, the FM Kirby Professor of Epistemology at the University of Pennsylvania School of Medicine, explore how the study of molecular genetics of inherited retinal degenerations can help develop treatments for congenital eye disorders, as well as adult-onset diseases and possibly disorders that affect the body outside the eye.

Host: Steven Edelman, MD Guest: Azza El-Remessy, PhD, RPh Retinopathy is one of the most common complications for patients living with diabetes but there are few treatment options and no early-stage interventions. How is research helping to pinpoint potential targets for early intervention and a possible oral treatment? Join host Dr. Steven Edelman and his guest, assistant professor and director of clinical and experimental therapeutics at the University of Georgia, Dr. Azza El-Remessy, as they discuss the latest research into the potential of statins to prevent diabetic-related blindness.

Host: Steven Edelman, MD Guest: Azza El-Remessy, PhD, RPh Retinopathy is one of the most common complications for patients living with diabetes but there are few treatment options and no early-stage interventions. How is research helping to pinpoint potential targets for early intervention and a possible oral treatment? Join host Dr. Steven Edelman and his guest, assistant professor and director of clinical and experimental therapeutics at the University of Georgia, Dr. Azza El-Remessy, as they discuss the latest research into the potential of statins to prevent diabetic-related blindness.

Host: Roy Levit, MD Guest: Alan Ruby, MD The standard treatment for proliferative and non-proliferative diabetic retinopathy is laser photocoagulation, but novel methods, including injectable steroids or anti-vascular endothelial growth factor, are also showing promise. What tests can help opthamologists determine the area of leakage in the eye that needs treatment? How soon after surgery will patients see a change in their vision? Dr. Alan Ruby, opthamologist and clinical assistant professor of biomedical sciences at the Eye Research Institute at Oakland University, in Rochester, Michigan, discusses ways to maximize the overall visual outcome for patients with diabetic retinopathy. How can diabetic retinopathy be prevented? Dr. Roy Levit hosts.

Host: Roy Levit, MD Guest: Alan Ruby, MD The eyes can yield clues to vascular issues elsewhere in the body. How can the two forms of diabetic retinopathy, which are non-proliferative and proliferative, affect vision, and how might retinopathy be associated with somatic effects resulting from diabetes? Dr. Alan Ruby, opthamologist and clinical assistant professor of biomedical sciences at the Eye Research Institute at Oakland University, in Rochester, Michigan, discusses the correlation between diabetic retinopathy and complications throughout the body. Can tight control of diabetes affect the progression or regression of retinopathy? What can physicians caring for patients with diabetes do to identify vision changes early on, and potentially reduce the risk of later complications? Dr. Roy Levit hosts.

Host: Roy Levit, MD Guest: Saad Shaikh, MD Although floaters in one's vision are common, this symptom can be a key indicator of a retinal tear or detachment. What is the incidence of retinal detachment in the U.S., and when should a primary care physician suspect this condition? Dr. Saad Shaikh, associate professor and member of the teaching faculty at the University of Central Florida College of Medicine in Orlando, and assistant professor at the University of South Florida, College of Medicine and at the Florida State College of Medicine, discusses the development of retinal detachments, risk factors, and the techniques used to correct the condition. Dr. Roy Levit hosts.

Host: Steven Edelman, MD Guest: Paul Tornambe, MD Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Join host Dr. Steven Edelman and his guest, ophthalmologist Dr. Paul Tornambe, an instructor in the departments of ophthalmology and family practice at the University of California, San Diego, as they discuss early diagnosis, tele-health and the exciting new VEGF inhibitors treatment of diabetic macular edema.

Host: Steven Edelman, MD Guest: Paul Tornambe, MD Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Join host Dr. Steven Edelman and his guest, ophthalmologist Dr. Paul Tornambe, an instructor in the departments of ophthalmology and family practice at the University of California, San Diego, as they discuss early diagnosis, tele-health and the exciting new VEGF inhibitors treatment of diabetic macular edema.

Host: Jennifer Shu, MD, FAAP Guest: David Abramson, MD Survival rates for retinoblastoma now approach 100 percent, but in years past, enucleation was the only sure way to cure this rare pediatric malignancy. We're now seeing advances in chemotherapy that not only spare the child's eye, but can preserve vision as well. What makes this chemotherapy regimen so effective, and how can we build on its effectiveness to enhance the vision and the livelihood of children affected by retinoblastoma? Dr. David Abramson, chief of the ophthalmic oncology service at Memorial Sloan-Kettering Cancer Center in New York, joins host Dr. Jennifer Shu to talk about the breadth of retinoblastoma research that has helped us take important strides toward remediation of this disease.

Host: Jennifer Shu, MD Guest: David Abramson, MD Survival rates for retinoblastoma now approach 100 percent, but in years past, enucleation was the only sure way to cure this rare pediatric malignancy. We're now seeing advances in chemotherapy that not only spare the child's eye, but can preserve vision as well. What makes this chemotherapy regimen so effective, and how can we build on its effectiveness to enhance the vision and the livelihood of children affected by retinoblastoma? Dr. David Abramson, chief of the ophthalmic oncology service at Memorial Sloan-Kettering Cancer Center in New York, joins host Dr. Jennifer Shu to talk about the breadth of retinoblastoma research that has helped us take important strides toward remediation of this disease.

Host: Lee Freedman, MD Guest: Frederick Vivino, MD Sjogren's syndrome is a commonly overlooked autoimmune disorder. Dry eyes and whole-body dryness are just two of the symptoms of Sjogren's syndrome that can suggest other conditions as well. How does Sjogren's present itself beyond dry eyes, and how severe is the condition? Dr. Frederick Vivino, clinical associate professor of medicine at the University of Pennsylvania School of Medicine, describes some of the tests and therapies available for Sjogren's syndrome to host Dr. Lee Freedman. Produced in Cooperation with

Host: Lee Freedman, MD Guest: Frederick Vivino, MD Sjogren's syndrome is a commonly overlooked autoimmune disorder. Dry eyes and whole-body dryness are just two of the symptoms of Sjogren's syndrome that can suggest other conditions as well. How does Sjogren's present itself beyond dry eyes, and how severe is the condition? Dr. Frederick Vivino, clinical associate professor of medicine at the University of Pennsylvania School of Medicine, describes some of the tests and therapies available for Sjogren's syndrome to host Dr. Lee Freedman. Produced in Cooperation with

Host: Lee Freedman, MD Guest: Frederick Vivino, MD Sjogren's syndrome is a commonly overlooked autoimmune disorder. Dry eyes and whole-body dryness are just two of the symptoms of Sjogren's syndrome that can suggest other conditions as well. How does Sjogren's present itself beyond dry eyes, and how severe is the condition? Dr. Frederick Vivino, clinical associate professor of medicine at the University of Pennsylvania School of Medicine, describes some of the tests and therapies available for Sjogren's syndrome to host Dr. Lee Freedman. Produced in Cooperation with

Host: Lee Freedman, MD Guest: Frederick Vivino, MD Sjogren's syndrome is a commonly overlooked autoimmune disorder. Dry eyes and whole-body dryness are just two of the symptoms of Sjogren's syndrome that can suggest other conditions as well. How does Sjogren's present itself beyond dry eyes, and how severe is the condition? Dr. Frederick Vivino, clinical associate professor of medicine at the University of Pennsylvania School of Medicine, describes some of the tests and therapies available for Sjogren's syndrome to host Dr. Lee Freedman. Produced in Cooperation with

Host: Roy Levit, MD Guest: Albert O. Edwards, MD, PhD Geneticists think of age-related macular degeneration (AMD) as a complex trait in which multiple environmental and epidemiological risks combine to cause the disease. Dr. Albert O. Edwards is a consultant and an opthalmologist at the Mayo Clinic in Minnesota, discusses with host Dr. Levitt the genetic approach for identifying biological pathways involved in the disease, and explains how to interpret the genetic studies. Dr. Edwards also outlines the importance of lifestyle choices, such as exercise, low-fat diet and other heart-healthy behaviors, to reduce their risk of developing AMD regardless of one's knowledge of the genetic risk. Tune in to hear Dr. Edwards clarify the relationship between genetics and AMD.

Host: Roy Levit, MD Guest: Allen Ho, MD What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment of macular hole and macular pucker. Before this surgical procedure, we had no cure for these diagnoses.

Host: Bruce Bloom, DDS, JD Guest: Mary Elizabeth Hartnett, MD Almost a third of all type I and type II diabetics develop macular edema. Join host Dr. Bruce Bloom and his guest, ophthalmologist, researcher and vitreo-retinal surgeon Dr. Mary Elizabeth Hartnett, professor of opthamology at the University of North Carolina at Chapel Hill School of Medicine, as they discuss the etiology and treatment of diabetic macular edema.

Host: Bruce Bloom, DDS, JD Guest: Mary Elizabeth Hartnett, MD Almost a third of all type I and type II diabetics develop macular edema. Join host Dr. Bruce Bloom and his guest, ophthalmologist, researcher and vitreo-retinal surgeon Dr. Mary Elizabeth Hartnett, professor of opthamology at the University of North Carolina at Chapel Hill School of Medicine, as they discuss the etiology and treatment of diabetic macular edema.

Host: Bruce Bloom, DDS, JD Guest: Mary Elizabeth Hartnett, MD Almost a third of all type I and type II diabetics develop macular edema. Join host Dr. Bruce Bloom and his guest, ophthalmologist, researcher and vitreo-retinal surgeon Dr. Mary Elizabeth Hartnett, professor of opthamology at the University of North Carolina at Chapel Hill School of Medicine, as they discuss the etiology and treatment of diabetic macular edema.

Host: Roy Levit, MD Guest: Mark Humayun, MD Microelectronic implants are restoring vision to the blind.Dr. Mark Humayun discusses with host Dr. Roy Levit the workings of the artificial retina and explains the surgical procedure to implant the device in the eye. The first generation of the implant only has 16 pixels while the second generation has 62 pixels. Dr. Humayun explains how the subjects who have the implant can initially see spots of light, but that the brain over time can fill in the details and many patients are able to see objects, motion and color. At this time, the implants are available only as a part of the clinical trial to subjects who are completely blind as a result of retinitis pigmentosa.

Host: Roy Levit, MD Dr. Richard Rosen, surgeon director for the department of ophthalmology and director of ophthalmic research in the Advanced Imaging Center at New York Eye and Ear Infirmary, joins host Dr. Roy Levit to discuss technologies and methods to examine the retina.

Host: Roy Levit, MD Guest: Cliff Ratner, MD Dr. Roy Levit welcomes Dr. Cliff Ratner to the Revealing Retina. Dr. Ratner did his residency at Harkness Eye Institute and a 2 Year Retina Fellowship at Wilmer Institute at Johns Hopkins. He has been in private practice for 25 years and is the founder of The Retina Practice of White Plains in New York. With his vast experience and expertise, he will talk about how much has changed and is currently changing in the treatment for Wet Macular Degeneration.

Host: Roy Levit, MD Guest: Paul Tornambe, MD Dr. Roy Levit welcomes Dr. Paul Tornambe to The Revealing Retina. Dr. Tornambe is in private practice in the San Diego/La Jolla area, and has written over a dozen peer reviewed papers on vitreo retinal disease. He lectures worldwide and is a Journal Referee for the AJO, Archives of Ophthalmology, Retina, British Journal of Ophthalmology, and the German Journal of Ophthalmology. He is a past president of the American Society of Retina Specialists. Dr. Tornambe will discuss the fact that because most residents eventually become board certified, the overall certification rate for the American Board of Ophthalmology (ABO) is not a discriminating educational outcome measure. He will talk about resident performance from program match to certification.

Host: Roy Levit, MD Guest: David Williams, MD Dr. Roy Levit welcomes Dr. David F. Williams to The Revealing Retina. Dr. Williams is a Vitreoretinal Specialist practicing in Minneapolis. He is currently Vice President as well as Program Chairman of the ASRS--American Society of Retina Specialists. Dr. Williams will discuss Wet Age-Related Macular Degeneration, also known as Neovascular AMD or Exudative AMD. He will highlight the symptoms and how to make a definitive diagnosis as well as the importance of the location of neovascular lesions as a vital factor affecting the progression of the disease and the risk of vision loss.

Host: Leslie P. Lundt, MD Guest: Dan Roam Tremendous leaps have been made in the science of vision giving us a better understanding of how we see. What do visual pathways teach us about the process of visual thinking? Host Dr. Leslie Lundt welcomes Dan Roam, author of The Back of the Napkin: Solving Problems and Selling Ideas with Pictures to discuss how we can use visual thinking techniques to improve our communication skills.

Host: Leslie P. Lundt, MD Guest: Dan Roam Tremendous leaps have been made in the science of vision giving us a better understanding of how we see. What do visual pathways teach us about the process of visual thinking? Host Dr. Leslie Lundt welcomes Dan Roam, author of The Back of the Napkin: Solving Problems and Selling Ideas with Pictures to discuss how we can use visual thinking techniques to improve our communication skills.

Host: Roy Levit, MD Guest: Michael Newton, MD Dr. Roy Levit is joined by Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. He has a Masters Degree in Bioethics, Science and Society from CUNY in New York City. Dr. Newton is the author of the book, "Without Your Consent, The Hijacking of American Health Care". They will discuss how the outside influences on healthcare has led to a loss of trust between doctor and patient.

Host: Roy Levit, MD Guest: Michael Newton, MD Dr. Roy Levit welcomes Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. They will dicuss Dr. Newton's book, "Without Your Consent, The Hijacking of American Health Care". They will cover all of the outside influences from managed care to hospitals to government that are influencing the way MD's practice medicine today.

Host: Roy Levit, MD Guest: Jerald Bovino, MD Dr. Roy Levit welcomes Dr. Jerald Bovino to the Revealing Retina. Dr. Bovino is a retired retinal surgeon who is well published in the area of physician retirement. Physician retirement issues will be explored and advice given. Some examples in the retinal field will be cited.

Host: Leslie P. Lundt, MD Guest: Michael Gordon, MD For many of us, one of the first signs of aging is presbyopia. In fact, the word comes from the Greek presbys which means old person. Other than growing longer arms or keeping a pair of reading glasses in every room, are there other treatments available? Host Dr. Leslie Lundt welcomes refractive surgeon Dr. Michael Gordon to discuss conductive keratoplasty (CK).

Host: Leslie P. Lundt, MD Guest: Michael Gordon, MD Until recently, many patients undergoing cataract surgery have subsequently needed bifocals or reading glasses to address hyperopia. The latest advances are changing patients' post-operative outlook. Dr. Michael Gordon, founder of the Gordon Binder Vision Institute in San Diego, joins host Dr. Leslie Lundt to discuss developments in this common area of concern in ophthalmology.

Host: Leslie P. Lundt, MD Guest: Michael Gordon, MD Myopia, or near-sightedness, affects approximately 25% of Americans between the ages of 12 and 54. Though glasses are the common quick fix to myopia, laser eye surgery has become more commonly used to correct vision problems since being introduced in the early 1990's. Though over 18 million LASIK procedures have been performed worldwide, some controversy still remains regarding the maximum possible correction and efficacy using this technique. What does the one of the country's top refractive surgeons have to say? Listen as host Dr. Leslie Lundt interviews one of the most respected eye surgeons in the country, Dr. Michael Gordon.

Host: Leslie P. Lundt, MD Guest: Michael Gordon, MD Until recently, many patients undergoing cataract surgery have subsequently needed bifocals or reading glasses to address hyperopia. The latest advances are changing patients' post-operative outlook. Dr. Michael Gordon, founder of the Gordon Binder Vision Institute in San Diego, joins host Dr. Leslie Lundt to discuss developments in this common area of concern in ophthalmology.

Host: Leslie P. Lundt, MD Guest: Michael Gordon, MD For many of us, one of the first signs of aging is presbyopia. In fact, the word comes from the Greek presbys which means old person. Other than growing longer arms or keeping a pair of reading glasses in every room, are there other treatments available? Host Dr. Leslie Lundt welcomes refractive surgeon Dr. Michael Gordon to discuss conductive keratoplasty (CK).

Host: Leslie P. Lundt, MD Guest: Michael Gordon, MD Myopia, or near-sightedness, affects approximately 25% of Americans between the ages of 12 and 54. Though glasses are the common quick fix to myopia, laser eye surgery has become more commonly used to correct vision problems since being introduced in the early 1990's. Though over 18 million LASIK procedures have been performed worldwide, some controversy still remains regarding the maximum possible correction and efficacy using this technique. What does the one of the country's top refractive surgeons have to say? Listen as host Dr. Leslie Lundt interviews one of the most respected eye surgeons in the country, Dr. Michael Gordon.

Host: Paul Raeburn Guest: Babak Parviz, PhD Paul Raeburn interviews Dr. Babak Parvis of the University of Washington about putting computers on contact lens. Pie in the Sky? Not if this scientist has anything to do with it.

Guest: Nicholas Zakov, MD Dr. Roy Levit welcomes Dr. Nicholas Zakov to the Revealing Retina. Dr. Zakov is a partner in Retina Associates of Cleveland, the largest Vitreoretinal group in Ohio and a clinical professor of Ophthalmology at University Hospitals Case Medical Center in Cleveland. They will be discussing the warning signs of flashes and floaters as well as common vs. uncommon causes and several treatments.

Host: Maurice Pickard, MD Guest: Richard King In his book “My Maggie,” Chicago sports anchor Rich King writes a powerful, complex, and memorable love story about his childhood sweetheart and wife of 32 years. Diagnosed with hearing loss at the age of four, Maggie wore cumbersome hearing aids and felt the humiliation of being "different." Slowly, an insidious disease later diagnosed as Usher Syndrome robbed her of vision. But she soldiered on, having fought three different cancers, changed careers in the middle of her life and fought to realize her dreams. Maggie King confronted this progressive disease with courage and dignity throughout her career in nursing and later as a strong advocate for the disabled.

Host: Maurice Pickard, MD Guest: Richard King In his book “My Maggie,” Chicago sports anchor Rich King writes a powerful, complex, and memorable love story about his childhood sweetheart and wife of 32 years. Diagnosed with hearing loss at the age of four, Maggie wore cumbersome hearing aids and felt the humiliation of being "different." Slowly, an insidious disease later diagnosed as Usher Syndrome robbed her of vision. But she soldiered on, having fought three different cancers, changed careers in the middle of her life and fought to realize her dreams. Maggie King confronted this progressive disease with courage and dignity throughout her career in nursing and later as a strong advocate for the disabled.

Host: Maurice Pickard, MD Guest: Richard King In his book “My Maggie,” Chicago sports anchor Rich King writes a powerful, complex, and memorable love story about his childhood sweetheart and wife of 32 years. Diagnosed with hearing loss at the age of four, Maggie wore cumbersome hearing aids and felt the humiliation of being "different." Slowly, an insidious disease later diagnosed as Usher Syndrome robbed her of vision. But she soldiered on, having fought three different cancers, changed careers in the middle of her life and fought to realize her dreams. Maggie King confronted this progressive disease with courage and dignity throughout her career in nursing and later as a strong advocate for the disabled.

Host: Maurice Pickard, MD Guest: Richard King In his book “My Maggie,” Chicago sports anchor Rich King writes a powerful, complex, and memorable love story about his childhood sweetheart and wife of 32 years. Diagnosed with hearing loss at the age of four, Maggie wore cumbersome hearing aids and felt the humiliation of being "different." Slowly, an insidious disease later diagnosed as Usher Syndrome robbed her of vision. But she soldiered on, having fought three different cancers, changed careers in the middle of her life and fought to realize her dreams. Maggie King confronted this progressive disease with courage and dignity throughout her career in nursing and later as a strong advocate for the disabled.

Host: Larry Kaskel, MD Guest: Mani Bhaumik, PhD The excimer laser was the key component to the invention of lasik surgery, responsible to returning nearly perfect vision to millions of people. How was the excimer laser developed and how did it turn into a miracle capable of correcting vision? Join Dr. Larry Kaskel talking with the co-inventor of the excimer laser, Dr. Mani Bhaumik.

Host: Larry Kaskel, MD Guest: Mani Bhaumik, PhD The excimer laser was the key component to the invention of lasik surgery, responsible to returning nearly perfect vision to millions of people. How was the excimer laser developed and how did it turn into a miracle capable of correcting vision? Join Dr. Larry Kaskel talking with the co-inventor of the excimer laser, Dr. Mani Bhaumik.

Host: Roy Levit, MD Guest: Julia Haller, MD Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. They will discuss the different types of macular degeneration, the demographics involved and who should be treating it.

Host: Roy Levit, MD Guest: Julia Haller, MD Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. Tune in to hear everything new in the treatment of macular degeneration.

Guest: Suber Huang, MD Tune in to hear the first in a monthly series entitled, "The Revealing Retina". Dr. Roy Levit, host and president of the American Retina Fundation, welcomes Dr. Suber Huang, Director of Vitreoretinal Diseases and Surgery at University Hospitals of Cleveland, and Medical Director and Treasurer for University Ophthalmologists, Inc. to discuss Diabetic Retinopathy, it's cause and effects. Listeners will gain information on how to understand and identify visual changes in their diabetic patients.

Guest: Suber Huang, MD Tune in to hear Dr. Roy Levit, host and president of the American Retina Fundation, as he welcomes Dr. Suber Huang, Director of Vitreoretinal Diseases and Surgery at University Hospitals of Cleveland, and Medical Director and Treasurer for University Ophthalmologists, Inc. Dr. Huang will discuss the intricacies of Diabetic Retinopathy.

Host: Maurice Pickard, MD Guest: Joel Kaplan, MD Dr. Maurice Pickard speaks to Dr. Joel Kaplan about some of the discrimination issues people with visual impairments face today, and the advocacy platforms founded through the Americans with Disability Act. Approximately 70% of blind Americans are unemployed, and for African Americans, that percentage is as high as 90%. Dr. Kaplan speaks to the increasing need for organizations like the Chicago Lighthouse to address these startling statistics. The segment concludes with a look at how progressively higher populations of senior citizens in America calls for greater blind/visually impaired-supportive resources, given the fact that the vast majority of cases are age-related.

Host: Maurice Pickard, MD Guest: Joel Kaplan, MD Dr. Maurice Pickard speaks with Dr. Joel Kaplan about the Chicago Lighthouse for People Who are Blind or Visually Impaired, including the institution itself and the various programs it provides. Its members work closely with the visually impaired at all age levels and provide numerous supportive resources for medical and social enrichment.

Host: Maurice Pickard, MD Guest: Joel Kaplan, MD Dr. Maurice Pickard speaks with Dr. Joel Kaplan about the Chicago Lighthouse for People Who are Blind or Visually Impaired, including the institution itself and the various programs it provides. Its members work closely with the visually impaired at all age levels and provide numerous supportive resources for medical and social enrichment.

Host: Maurice Pickard, MD Guest: Joel Kaplan, MD Dr. Maurice Pickard speaks to Dr. Joel Kaplan about some of the discrimination issues people with visual impairments face today, and the advocacy platforms founded through the Americans with Disability Act. Approximately 70% of blind Americans are unemployed, and for African Americans, that percentage is as high as 90%. Dr. Kaplan speaks to the increasing need for organizations like the Chicago Lighthouse to address these startling statistics. The segment concludes with a look at how progressively higher populations of senior citizens in America calls for greater blind/visually impaired-supportive resources, given the fact that the vast majority of cases are age-related.

Host: Michael Greenberg, MD Guest: Bruce Goldstick, MD Dr. Michael Greenberg speaks with Dr. Bruce Goldstick about his experience creating a clinic for eye patients in Kiev, Ukraine.

Host: Michael Greenberg, MD Guest: Bruce Goldstick, MD Dr. Michael Greenberg speaks with Dr. Bruce Goldstick about his experience creating a clinic for eye patients in Kiev, Ukraine.

Host: Larry Kaskel, MD Guest: Elise Torczynski, MD Dr. Elise Torcynski, ophthalmic pathologist, and expert witness in over 20 SBS cases will discuss aspects of the syndrome itself as well as the retinal implications.

Host: Larry Kaskel, MD Guest: Elise Torczynski, MD Dr. Elise Torcynski, ophthalmic pathologist, and expert witness in over 20 SBS cases will discuss aspects of the syndrome itself as well as the retinal implications.